BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22425625)

  • 1. Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential.
    Jo J; Bengsch B; Seigel B; Rau SJ; Schmidt J; Bisse E; Aichele P; Aichele U; Joeckel L; Royer C; Sá Ferreira K; Borner C; Baumert TF; Blum HE; Lohmann V; Fischer R; Thimme R
    J Hepatol; 2012 Jul; 57(1):9-16. PubMed ID: 22425625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
    Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
    Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.
    Bonorino P; Leroy V; Dufeu-Duchesne T; Tongiani-Dashan S; Sturm N; Pernollet M; Vivier E; Zarski JP; Marche PN; Jouvin-Marche E
    Hepatology; 2007 Nov; 46(5):1375-86. PubMed ID: 17668887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection.
    Nisii C; Tempestilli M; Agrati C; Poccia F; Tocci G; Longo MA; D'Offizi G; Tersigni R; Lo Iacono O; Antonucci G; Oliva A
    J Hepatol; 2006 Mar; 44(3):475-83. PubMed ID: 16426698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.
    Chang KM; Thimme R; Melpolder JJ; Oldach D; Pemberton J; Moorhead-Loudis J; McHutchison JG; Alter HJ; Chisari FV
    Hepatology; 2001 Jan; 33(1):267-76. PubMed ID: 11124845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation.
    Northfield JW; Kasprowicz V; Lucas M; Kersting N; Bengsch B; Kim A; Phillips RE; Walker BD; Thimme R; Lauer G; Klenerman P
    Hepatology; 2008 Feb; 47(2):396-406. PubMed ID: 18219672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
    Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
    J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic CD4 T cells in viral hepatitis.
    Aslan N; Yurdaydin C; Wiegand J; Greten T; Ciner A; Meyer MF; Heiken H; Kuhlmann B; Kaiser T; Bozkaya H; Tillmann HL; Bozdayi AM; Manns MP; Wedemeyer H
    J Viral Hepat; 2006 Aug; 13(8):505-14. PubMed ID: 16901280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of proliferation and differentiation of CD8+ T cells on the progression in patients co-infected with HIV and HCV].
    Zhang YH; Zhao Y; Ma LN; Shi LX; Jin Y; He ZM; Zhang XD; Chen XY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):331-3. PubMed ID: 20387477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
    Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
    Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.
    Ando K; Hiroishi K; Kaneko T; Moriyama T; Muto Y; Kayagaki N; Yagita H; Okumura K; Imawari M
    J Immunol; 1997 Jun; 158(11):5283-91. PubMed ID: 9164947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
    J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
    Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
    Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection.
    Rodrigue-Gervais IG; Rigsby H; Jouan L; Sauvé D; Sékaly RP; Willems B; Lamarre D
    J Immunol; 2010 Mar; 184(6):3134-44. PubMed ID: 20173023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.